Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
liver disease
2
×
national blog main
national top stories
new york blog main
3m
ace
acelity
acetylon pharmaceuticals
acquisition
allergan
ambys medicines
apax partners
biotech
boston blog main
boston top stories
botox
breast implant
breast reconstruction
buyout
cell therapy
chase pharmaceutical corp.
china
constellation pharmaceuticals
deals
debt
electronics
employment
energy
exome
fired
gene therapy
genentech
holger willenbring
ipo
jeffrey tong
job cut
jobs
joe woody
juan carlos izpisua belmonte
What
deal
2
×
ace
acelity
acquired
aiming
ambys
antonio
bandages
big
billion
biotech
control
deadly
debuted
diseases
ending
formed
future
ipo
launch
liver
make
maker
medicines
new
plan
post
products
san
sells
startup
takeda
today
treatments
unusual
valued
variety
weeks
Language
Current search:
deal
×
" liver disease "
×
@xconomy.com
5 years ago
Acelity Sells to 3M in Deal Valued at $6.7 Billion, Ending IPO Plan
@xconomy.com
5 years ago
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?
